118 related articles for article (PubMed ID: 8662772)
1. Binding specificity and mutational analysis of the phosphotyrosine binding domain of the brain-specific adaptor protein ShcC.
O'Bryan JP; Martin CB; Songyang Z; Cantley LC; Der CJ
J Biol Chem; 1996 May; 271(20):11787-91. PubMed ID: 8662772
[TBL] [Abstract][Full Text] [Related]
2. A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain.
O'Bryan JP; Songyang Z; Cantley L; Der CJ; Pawson T
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2729-34. PubMed ID: 8610109
[TBL] [Abstract][Full Text] [Related]
3. The src homology 2 and phosphotyrosine binding domains of the ShcC adaptor protein function as inhibitors of mitogenic signaling by the epidermal growth factor receptor.
O'Bryan JP; Lambert QT; Der CJ
J Biol Chem; 1998 Aug; 273(32):20431-7. PubMed ID: 9685397
[TBL] [Abstract][Full Text] [Related]
4. Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites.
van der Geer P; Wiley S; Gish GD; Lai VK; Stephens R; White MF; Kaplan D; Pawson T
Proc Natl Acad Sci U S A; 1996 Feb; 93(3):963-8. PubMed ID: 8577769
[TBL] [Abstract][Full Text] [Related]
5. A family of Shc related proteins with conserved PTB, CH1 and SH2 regions.
Pelicci G; Dente L; De Giuseppe A; Verducci-Galletti B; Giuli S; Mele S; Vetriani C; Giorgio M; Pandolfi PP; Cesareni G; Pelicci PG
Oncogene; 1996 Aug; 13(3):633-41. PubMed ID: 8760305
[TBL] [Abstract][Full Text] [Related]
6. Differential utilization of ShcA tyrosine residues and functional domains in the transduction of epidermal growth factor-induced mitogen-activated protein kinase activation in 293T cells and nerve growth factor-induced neurite outgrowth in PC12 cells. Identification of a new Grb2.Sos1 binding site.
Thomas D; Bradshaw RA
J Biol Chem; 1997 Aug; 272(35):22293-9. PubMed ID: 9268379
[TBL] [Abstract][Full Text] [Related]
7. [Functional roles of phosphotyrosine adaptor Shc in the brain].
Kakizawa S
Nihon Yakurigaku Zasshi; 2018; 152(2):84-89. PubMed ID: 30101865
[TBL] [Abstract][Full Text] [Related]
8. Binding affinities of tyrosine-phosphorylated peptides to the COOH-terminal SH2 and NH2-terminal phosphotyrosine binding domains of Shc.
Zhou MM; Harlan JE; Wade WS; Crosby S; Ravichandran KS; Burakoff SJ; Fesik SW
J Biol Chem; 1995 Dec; 270(52):31119-23. PubMed ID: 8537373
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the phosphotyrosine-binding domain of the Drosophila Shc protein.
Li SC; Lai KM; Gish GD; Parris WE; van der Geer P; Forman-Kay J; Pawson T
J Biol Chem; 1996 Dec; 271(50):31855-62. PubMed ID: 8943228
[TBL] [Abstract][Full Text] [Related]
10. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
[TBL] [Abstract][Full Text] [Related]
11. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.
Sakaguchi K; Okabayashi Y; Kido Y; Kimura S; Matsumura Y; Inushima K; Kasuga M
Mol Endocrinol; 1998 Apr; 12(4):536-43. PubMed ID: 9544989
[TBL] [Abstract][Full Text] [Related]
12. Re-engineering the target specificity of the insulin receptor by modification of a PTB domain binding site.
van der Geer P; Wiley S; Pawson T
Oncogene; 1999 May; 18(20):3071-5. PubMed ID: 10340378
[TBL] [Abstract][Full Text] [Related]
13. Specificity of the PTB domain of Shc for beta turn-forming pentapeptide motifs amino-terminal to phosphotyrosine.
TrĂ¼b T; Choi WE; Wolf G; Ottinger E; Chen Y; Weiss M; Shoelson SE
J Biol Chem; 1995 Aug; 270(31):18205-8. PubMed ID: 7543098
[TBL] [Abstract][Full Text] [Related]
14. Interaction between the phosphotyrosine binding domain of Shc and the insulin receptor is required for Shc phosphorylation by insulin in vivo.
Isakoff SJ; Yu YP; Su YC; Blaikie P; Yajnik V; Rose E; Weidner KM; Sachs M; Margolis B; Skolnik EY
J Biol Chem; 1996 Feb; 271(8):3959-62. PubMed ID: 8626723
[TBL] [Abstract][Full Text] [Related]
15. Affinity, specificity, and kinetics of the interaction of the SHC phosphotyrosine binding domain with asparagine-X-X-phosphotyrosine motifs of growth factor receptors.
Laminet AA; Apell G; Conroy L; Kavanaugh WM
J Biol Chem; 1996 Jan; 271(1):264-9. PubMed ID: 8550571
[TBL] [Abstract][Full Text] [Related]
16. The ShcA phosphotyrosine docking protein uses distinct mechanisms to regulate myocyte and global heart function.
Vanderlaan RD; Hardy WR; Kabir MG; Pasculescu A; Jones N; deTombe PP; Backx PH; Pawson T
Circ Res; 2011 Jan; 108(2):184-93. PubMed ID: 21148430
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a role for the phosphotyrosine-binding domain of Shc in interleukin 2 signaling.
Ravichandran KS; Igras V; Shoelson SE; Fesik SW; Burakoff SJ
Proc Natl Acad Sci U S A; 1996 May; 93(11):5275-80. PubMed ID: 8643566
[TBL] [Abstract][Full Text] [Related]
18. Identification of residues within the SHC phosphotyrosine binding/phosphotyrosine interaction domain crucial for phosphopeptide interaction.
Yajnik V; Blaikie P; Bork P; Margolis B
J Biol Chem; 1996 Jan; 271(4):1813-6. PubMed ID: 8567619
[TBL] [Abstract][Full Text] [Related]
19. The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein-protein interactions.
van der Geer P; Wiley S; Gish GD; Pawson T
Curr Biol; 1996 Nov; 6(11):1435-44. PubMed ID: 8939605
[TBL] [Abstract][Full Text] [Related]
20. Disruption of ShcA signaling halts cell proliferation--characterization of ShcC residues that influence signaling pathways using yeast.
Heinrich JN; Kwak SP; Howland DS; Chen J; Sturner S; Sullivan K; Lipinski K; Cheng KY; She Y; Lo F; Ghavami A
Cell Signal; 2006 Jun; 18(6):795-806. PubMed ID: 16126371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]